Cargando…
Organ transplantation and drug eluting stents: Perioperative challenges
Patients listed for organ transplant frequently have severe coronary artery disease (CAD), which may be treated with drug eluting stents (DES). Everolimus and zotarolimus eluting stents are commonly used. Newer generation biolimus and novolimus eluting biodegradable stents are becoming increasingly...
Autor principal: | Dalal, Aparna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175219/ https://www.ncbi.nlm.nih.gov/pubmed/28058211 http://dx.doi.org/10.5500/wjt.v6.i4.620 |
Ejemplares similares
-
Perioperative management of antiplatelet therapy in patients with drug-eluting stents
por: Dimitrova, G, et al.
Publicado: (2012) -
Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update
por: Llau, Juan V, et al.
Publicado: (2010) -
Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019) -
Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?
por: Gherasie, Flavius-Alexandru, et al.
Publicado: (2023) -
Drug-eluting metallic stents in urology
por: Kallidonis, Panagiotis S., et al.
Publicado: (2014)